Article
Identification of novel genes by whole-exome sequencing can improve gastric cancer precision oncology.
Future oncology (London, England) - 1 Apr 2017
Lianos Georgios D, Glantzounis Georgios K, Bali Christina D, Katsios Christos, Roukos Dimitrios H
Abstract excerpt
AIM: By identifying cancer driver genes involved in tumorigenesis, whole-exome sequencing (WES) analyses enable the development of robust biomarkers and novel therapeutic targets to reach precision oncology. PATIENTS & METHODS: WES analyses were performed in matched gastric cancer-normal gastric tissues from two patients. We compared genes highlighted with those of a database and recent WES/whole-genome...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
